Steve Flynn, PharmD, BCPS

Article

Potential Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients With Chronic Myeloid Leukemia in a VA Regional Network

Author:

Steve Flynn, PharmD, BCPS

Chronic myeloid leukemia (CML) is a hematologic malignancy resulting from an acquired mutation.

• Read More